New cancer drugs are very expensive: here’s how we work out value for our money.

Jonathan Karnon; Hossein Haji Ali Afzali; Laura C Edney

New cancer drugs are very expensive: here’s how we work out value for our money.

Jonathan Karnon, Hossein Haji Ali Afzali, Laura C Edney

Research output: Other contribution

Abstract

The Senate Standing Committee on Community Affairs is expected to table its report on the “Availability of new, innovative and specialist cancer drugs in Australia” today. Initiated by South Australian senator Nick Xenophon, the inquiry, which was initially slated to report in late March, is focusing on timely access and affordability of cancer drugs, and how this impacts the quality of cancer care.

Original language	English
Publisher	The Conversation
Place of Publication	Australia
Publication status	Published - 9 Sept 2015
Externally published	Yes

Keywords

PBS
health economics
PBAC
cancer drugs

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

http://theconversation.com/new-cancer-drugs-are-very-expensive-heres-how-we-work-out-value-for-our-money-44014Licence: CC BY

Cite this

@misc{42bcefb2099d494c974ecdc55ba301ef,

title = "New cancer drugs are very expensive: here{\textquoteright}s how we work out value for our money.",

abstract = "The Senate Standing Committee on Community Affairs is expected to table its report on the “Availability of new, innovative and specialist cancer drugs in Australia” today. Initiated by South Australian senator Nick Xenophon, the inquiry, which was initially slated to report in late March, is focusing on timely access and affordability of cancer drugs, and how this impacts the quality of cancer care.",

keywords = "PBS, health economics, PBAC, cancer drugs",

author = "Jonathan Karnon and {Haji Ali Afzali}, Hossein and Edney, {Laura C}",

year = "2015",

month = sep,

day = "9",

language = "English",

publisher = "The Conversation",

type = "Other",

}

TY - GEN

T1 - New cancer drugs are very expensive

T2 - here’s how we work out value for our money.

AU - Karnon, Jonathan

AU - Haji Ali Afzali, Hossein

AU - Edney, Laura C

PY - 2015/9/9

Y1 - 2015/9/9

N2 - The Senate Standing Committee on Community Affairs is expected to table its report on the “Availability of new, innovative and specialist cancer drugs in Australia” today. Initiated by South Australian senator Nick Xenophon, the inquiry, which was initially slated to report in late March, is focusing on timely access and affordability of cancer drugs, and how this impacts the quality of cancer care.

AB - The Senate Standing Committee on Community Affairs is expected to table its report on the “Availability of new, innovative and specialist cancer drugs in Australia” today. Initiated by South Australian senator Nick Xenophon, the inquiry, which was initially slated to report in late March, is focusing on timely access and affordability of cancer drugs, and how this impacts the quality of cancer care.

KW - PBS

KW - health economics

KW - PBAC

KW - cancer drugs

M3 - Other contribution

PB - The Conversation

CY - Australia

ER -

New cancer drugs are very expensive: here’s how we work out value for our money.

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this